Enveric Biosciences, Inc. (ENVB)
1.42
+0.04
(+2.90%)
USD |
NASDAQ |
Oct 27, 16:00
1.44
+0.02
(+1.41%)
After-Hours: 20:00
Enveric Biosciences Price to Book Value : 0.6915 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 0.6915 |
| October 26, 2026 | 0.672 |
| October 23, 2026 | 0.6818 |
| October 22, 2026 | 0.711 |
| October 21, 2026 | 0.7353 |
| October 20, 2026 | 0.7012 |
| October 19, 2026 | 0.6769 |
| October 16, 2026 | 0.672 |
| October 15, 2026 | 0.6769 |
| October 14, 2026 | 0.6671 |
| October 13, 2026 | 0.6818 |
| October 12, 2026 | 0.7158 |
| October 09, 2026 | 0.7061 |
| October 08, 2026 | 0.7402 |
| October 07, 2026 | 0.728 |
| October 06, 2026 | 0.7158 |
| October 05, 2026 | 0.7353 |
| October 02, 2026 | 0.7207 |
| October 01, 2026 | 0.711 |
| September 30, 2026 | 0.7231 |
| September 29, 2026 | 0.7061 |
| September 28, 2026 | 0.7158 |
| September 25, 2026 | 0.7304 |
| September 24, 2026 | 0.7524 |
| September 23, 2026 | 0.7621 |
| Date | Value |
|---|---|
| September 22, 2026 | 0.7499 |
| September 21, 2026 | 0.7597 |
| September 18, 2026 | 0.7889 |
| September 17, 2026 | 0.7743 |
| September 16, 2026 | 0.7256 |
| September 15, 2026 | 0.711 |
| September 14, 2026 | 0.7207 |
| September 11, 2026 | 0.6915 |
| September 10, 2026 | 0.711 |
| September 09, 2026 | 0.7085 |
| September 08, 2026 | 0.6915 |
| September 04, 2026 | 0.6769 |
| September 03, 2026 | 0.7012 |
| September 02, 2026 | 0.7012 |
| September 01, 2026 | 0.6671 |
| August 31, 2026 | 0.6671 |
| August 28, 2026 | 0.6671 |
| August 27, 2026 | 0.6671 |
| August 26, 2026 | 0.6671 |
| August 25, 2026 | 0.711 |
| August 24, 2026 | 0.6866 |
| August 21, 2026 | 0.6964 |
| August 20, 2026 | 0.6769 |
| August 19, 2026 | 0.6379 |
| August 18, 2026 | 0.6574 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| LENZ Therapeutics, Inc. | 0.4513 |
| Impact BioMedical, Inc. | 2.817 |
| ANI Pharmaceuticals, Inc. | 2.738 |
| Corcept Therapeutics, Inc. | 13.39 |
| Veru, Inc. | 1.37 |
Price to Book Value Related Metrics
| Price | 1.42 |
| Earnings Yield | -1.16K% |
| Market Cap | 5.589M |